Literature DB >> 30693395

Pattern of sleep dysfunction in systemic lupus erythematosus: a cluster analysis.

Domenico Paolo Emanuele Margiotta1, Alice Laudisio2, Luca Navarini3, Fabio Basta1, Carmen Mazzuca1, Silvia Angeletti4, Massimo Ciccozzi4, Raffaele Antonelli Incalzi2, Antonella Afeltra1.   

Abstract

OBJECTIVES: To investigate how the different components of sleep dysfunction described in SLE patients combine together in sleep clusters.
METHODS: We conducted a cross-sectional study on a perspective cohort of 79 SLE patients (mean age 8.2 ± 14.3 years). Sleep was evaluated using Pittsburgh Sleep Quality Index (PSQI). Clusters were defined using the single components of PSQI in a hierarchical clustering model. We used Beck Depression Inventory, Hamilton Anxiety Rating Scale, and Medical Outcomes Study Short Form 36 (SF36) to measure depressive symptoms, anxiety, and quality of life, respectively.
RESULTS: Three sleep clusters were identified. The cluster 1 (N = 47) is characterized by the lowest values of PSQI total score. The cluster 2 (N = 21) presents higher values of sleep latency, but sleep duration similar to cluster 1. In cluster 3 (N = 11), we found sleep latency increased as in cluster 2, but the highest values of PSQI total score and reduced sleep duration. Scores of anxiety and sedentary time were higher in clusters 2 and 3 than in cluster 1. Cluster 3 presented the highest scores of depression and reduced mental and physical components of SF36.
CONCLUSIONS: The combination of different sleep components in SLE patients allowed us to identify three patterns of dysfunction: a first cluster with better sleep latency and duration, a second with increased sleep latency but conserved duration, and a third with impairment of both latency and duration. The stratification of sleep disorders in clusters might be useful for the personalization of therapy in relation to sleep cluster membership.

Entities:  

Keywords:  Anxiety (MeSH); Lupus erythematosus; Quality of life (MeSH); Sedentary behavior; Sleep (MeSH); Systemic (MeSH)

Mesh:

Year:  2019        PMID: 30693395     DOI: 10.1007/s10067-018-04410-3

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  46 in total

1.  The metabolic syndrome--a new worldwide definition.

Authors:  K George M M Alberti; Paul Zimmet; Jonathan Shaw
Journal:  Lancet       Date:  2005 Sep 24-30       Impact factor: 79.321

2.  The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial.

Authors:  Jill P Buyon; Michelle A Petri; Mimi Y Kim; Kenneth C Kalunian; Jennifer Grossman; Bevra H Hahn; Joan T Merrill; Lisa Sammaritano; Michael Lockshin; Graciela S Alarcón; Susan Manzi; H Michael Belmont; Anca D Askanase; Lisa Sigler; Mary Anne Dooley; Joan Von Feldt; W Joseph McCune; Alan Friedman; Jane Wachs; Mary Cronin; Michelene Hearth-Holmes; Mark Tan; Frederick Licciardi
Journal:  Ann Intern Med       Date:  2005-06-21       Impact factor: 25.391

3.  Determinants of sleep quality in women with systemic lupus erythematosus.

Authors:  Deborah Da Costa; Sasha Bernatsky; Maria Dritsa; Ann E Clarke; Kaberi Dasgupta; Anahita Keshani; Christian Pineau
Journal:  Arthritis Rheum       Date:  2005-04-15

4.  Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE.

Authors:  C Bombardier; D D Gladman; M B Urowitz; D Caron; C H Chang
Journal:  Arthritis Rheum       Date:  1992-06

5.  Psychopathological dimensions of depression: a factor study of the 17-item Hamilton depression rating scale in unipolar depressed outpatients.

Authors:  P Pancheri; A Picardi; M Pasquini; P Gaetano; M Biondi
Journal:  J Affect Disord       Date:  2002-02       Impact factor: 4.839

6.  Combined oral contraceptives in women with systemic lupus erythematosus.

Authors:  Michelle Petri; Mimi Y Kim; Kenneth C Kalunian; Jennifer Grossman; Bevra H Hahn; Lisa R Sammaritano; Michael Lockshin; Joan T Merrill; H Michael Belmont; Anca D Askanase; W Joseph McCune; Michelene Hearth-Holmes; Mary Anne Dooley; Joan Von Feldt; Alan Friedman; Mark Tan; John Davis; Mary Cronin; Betty Diamond; Meggan Mackay; Lisa Sigler; Michael Fillius; Ann Rupel; Frederick Licciardi; Jill P Buyon
Journal:  N Engl J Med       Date:  2005-12-15       Impact factor: 91.245

7.  Objective and subjective sleep disturbances in patients with systemic lupus erythematosus.

Authors:  M Valencia-Flores; M Resendiz; V A Castaño; V Santiago; R M Campos; S Sandino; X Valencia; J Alcocer; G G Ramos; D L Bliwise
Journal:  Arthritis Rheum       Date:  1999-10

8.  Neuropsychiatric lupus syndromes: relationship with antiphospholipid antibodies.

Authors:  Antonella Afeltra; Pierluigi Garzia; Anna Paola Mitterhofer; Marta Vadacca; Sara Galluzzo; Flavia Del Porto; Licia Finamore; Stefano Pascucci; Marina Gasparini; Bruno Laganà; Domenico Caccavo; Giovanni Maria Ferri; Antonio Amoroso; Ada Francia
Journal:  Neurology       Date:  2003-07-08       Impact factor: 9.910

9.  Self-reported sleep in systemic lupus erythematosus.

Authors:  Kenneth Mark Greenwood; Leah Lederman; Helen Dawn Lindner
Journal:  Clin Rheumatol       Date:  2008-04-12       Impact factor: 2.980

Review 10.  The Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System: properties, applications, and interpretation.

Authors:  Kimberly Webster; David Cella; Kathleen Yost
Journal:  Health Qual Life Outcomes       Date:  2003-12-16       Impact factor: 3.186

View more
  2 in total

1.  An evaluation of sleep habits and childhood-onset systemic lupus erythematosus.

Authors:  Gizem Durcan; Sezgin Sahin; Zehra Koyuncu; Mehmet Yıldız; Elif Hacıvelioglu; Fatih Haslak; Amra Adrovic; Kenan Barut; Aybuke Gunalp; Burak Dogangun; Ozgur Kasapcopur
Journal:  Clin Rheumatol       Date:  2022-05-31       Impact factor: 3.650

Review 2.  Sleep Problems in Chronic Inflammatory Diseases: Prevalence, Treatment, and New Perspectives: A Narrative Review.

Authors:  Marta Ditmer; Agata Gabryelska; Szymon Turkiewicz; Piotr Białasiewicz; Ewa Małecka-Wojciesko; Marcin Sochal
Journal:  J Clin Med       Date:  2021-12-23       Impact factor: 4.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.